CNBC December 16, 2025
Annika Kim Constantino

GLP-1 pills for obesity are closer than ever.

2026 is likely the year that two new oral weight loss drugs will reach patients in the U.S. For some people, pills may serve as a more convenient — and potentially in certain cases cheaper — alternative to today’s blockbuster injections.

Drugmakers Novo Nordisk and Eli Lilly have said their daily pills could help the drugs reach new patients. That could include people who are afraid of needles or patients who might benefit from the existing injections but don’t take them because they don’t view their need as severe enough.

The upcoming pills aren’t expected to be more effective than weekly injections, but health experts stress that expanding the range...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma / Biotech
What’s new with GLP-1s
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
Medicare Is Covering GLP-1s – It’s Time to Cover the Care That Makes Them Sustainable

Share Article